No Detail Found!

Development and validation of RP-HPLC method for the simultaneous determination of azilsartan medoxomil and chlorthalidone in solid dosage form

Author(s)
Muhammad Jahangir Department of Chemistry, Government College University,Lahore,Pakistan
Arooj Azhar Department of Chemistry, Government College University,Lahore,Pakistan
Aymen Awan Department of Chemistry, Government College University,Lahore,Pakistan
Abstract
The fixed dose combination of azilsartan medoxomil and chlorthalidone has been effectively used to treat hypertension. Development of a specific and accurate Reverse-Phase HPLC method for simultaneous estimation of AZL and CLR was main objective of this study that was used for simultaneous quantification of these drugs in human plasma. The method used 30:70 acetonitrile and water as mobile phase, thermo-scientific ODS hypersil C18 column (250 × 4.6 mm, 5µm),1.2mL/min flow rate analyzed at 230nm. The retention time was 1.61 and 4.12 for AZL and CLR respectively. All the validation parameters of proposed method were performed. Linearity was found 0.9991 R2 for the concentration of 3-22µg/ml for CLR and 0.9997 for concentration 10-70µg/ml for AZL. The inter-day and intraday precision were found 0.37 and 0.20 for AZL and 0.83 and 0.34 for CLR. LOD of AZL and CLR was 0.010µg/mL and 0.016µg/ml while LOQ was 0.032µg/mL and 0.048µg/mL for AZL and CLR respectively. The method was found to be effective in AZL and CLR quantification for pharmacokinetic study in human blood plasma.
Publication Details
Page(s) 1053-1061
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
RP-HPLC, Validation, Azilsartan medoxomil, chlorthalidone, stress degradation
0

Citations

0

Downloads

97

Views